Published in J Clin Invest on April 01, 1995
Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res (2000) 3.03
Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin. Arthritis Res Ther (2004) 2.58
Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res (2001) 2.18
In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum. Clin Exp Immunol (2000) 1.77
Insights into rheumatoid arthritis derived from the Sa immune system. Arthritis Res (2000) 1.23
Cloning of novel soluble gp130 and detection of its neutralizing autoantibodies in rheumatoid arthritis. J Clin Invest (2000) 0.92
Serum samples of patients with rheumatoid arthritis contain a specific autoantibody to "denatured" aldolase A in the osteoblast-like cell line, MG-63. Ann Rheum Dis (1999) 0.86
Overexpression of a minimal domain of calpastatin suppresses IL-6 production and Th17 development via reduced NF-κB and increased STAT5 signals. PLoS One (2011) 0.79
Antibodies against a novel nucleolar and cytoplasmic antigen (p105-p42) present in the sera of patients with a subset of rheumatoid arthritis (RA) with signs of scleroderma. Clin Exp Immunol (1998) 0.79
The challenge of early synovitis: multiple pathways to a common clinical syndrome. Arthritis Res (1999) 0.78
Posttranslational Protein Modification in the Salivary Glands of Sjögren's Syndrome Patients. Autoimmune Dis (2013) 0.78
Autoantibodies directed against the protease inhibitor calpastatin in psoriasis. Clin Exp Immunol (2005) 0.77
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum (1988) 111.05
Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene (1988) 52.71
Calcium-activated neutral protease (calpain) system: structure, function, and regulation. Physiol Rev (1991) 3.53
The Sa system: a novel antigen-antibody system specific for rheumatoid arthritis. J Rheumatol (1994) 2.44
The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis. J Clin Invest (1993) 2.37
Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest (1989) 2.33
Involvement of the chaperonin dnaK in the rapid degradation of a mutant protein in Escherichia coli. EMBO J (1992) 2.29
Autoantibodies in pathology and cell biology. Cell (1991) 1.93
Expression of metalloproteinases and metalloproteinase inhibitor in human arthritic synovium. Arthritis Rheum (1991) 1.73
Calpain activation in apoptosis. J Cell Physiol (1994) 1.72
Antiperinuclear factor, a marker autoantibody for rheumatoid arthritis: colocalisation of the perinuclear factor and profilaggrin. Ann Rheum Dis (1991) 1.68
The role of autoantibodies in autoimmune disease. Annu Rev Immunol (1993) 1.28
Purification and partial sequencing of the nuclear autoantigen RA33 shows that it is indistinguishable from the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. J Clin Invest (1992) 1.26
Immune mechanisms in Graves' disease. Endocr Rev (1985) 1.25
Interference of Wegener's granulomatosis autoantibodies with neutrophil Proteinase 3 activity. Clin Exp Immunol (1992) 1.22
Stimulation of the secretion of latent cysteine proteinase activity by tumor necrosis factor alpha and interleukin-1. Arthritis Rheum (1993) 1.11
Cytokines and proteases in invasive processes: molecular similarities between inflammation and cancer. Cytokine (1992) 1.04
Cysteine proteinase inhibitors decrease articular cartilage and bone destruction in chronic inflammatory arthritis. Arthritis Rheum (1994) 1.03
Modulation of cellular signals by calpain. Ann N Y Acad Sci (1992) 1.02
All four repeating domains of the endogenous inhibitor for calcium-dependent protease independently retain inhibitory activity. Expression of the cDNA fragments in Escherichia coli. J Biol Chem (1988) 0.95
Extracellular appearance of calpain and calpastatin in the synovial fluid of the knee joint. Biochem Biophys Res Commun (1989) 0.95
Isolation and characterization of cDNA clones for human erythrocyte beta-spectrin. Proc Natl Acad Sci U S A (1987) 0.94
Determination of cathepsins B and H in sera and synovial fluids of patients with different joint diseases. J Clin Chem Clin Biochem (1990) 0.93
Human cathepsin B and cysteine proteinase inhibitors (CPIs) in inflammatory and metabolic joint diseases. Biol Chem Hoppe Seyler (1988) 0.91
Calcium-dependent cysteine proteinase (calpain) in human arthritic synovial joints. Arthritis Rheum (1992) 0.91
cDNA cloning of human calpastatin: sequence homology among human, pig, and rabbit calpastatins. J Enzyme Inhib (1989) 0.89
Biochemical demonstration of calpains and calpastatin in osteoarthritic synovial fluid. Arthritis Rheum (1990) 0.88
Myasthenia gravis: prototype of the antireceptor autoimmune diseases. Int Rev Neurobiol (1990) 0.88
Characterization of proteoglycan degradation by calpain. Biochem J (1992) 0.86
Measurement of elastase and cysteine proteinases in synovial fluid of patients with rheumatoid arthritis, sero-negative spondylarthropathies, and osteoarthritis. Clin Chem (1992) 0.84
Molecular biology of nuclear autoantigens. Rheum Dis Clin North Am (1992) 0.80
Autoantibody-facilitated proteolytic cleavage: a new pathogenic mechanism in autoimmunity. Biochem Soc Trans (1991) 0.77
Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res (2000) 3.03
The Sa system: a novel antigen-antibody system specific for rheumatoid arthritis. J Rheumatol (1994) 2.44
Sera from patients with autoimmune disease recognize conformational determinants on the 60-kd Ro/SS-A protein. Arthritis Rheum (1991) 1.85
Primary septic arthritis in heroin users: early diagnosis by radioisotopic imaging and geographic variations in the causative agents. J Rheumatol (1987) 1.46
[Learning through problem-solving and the case of the fortuitoma]. Union Med Can (1992) 1.39
Antinuclear antibodies: the medium is the message. Clin Exp Rheumatol (2000) 1.38
Airways disease in rheumatoid arthritis patients. One element of a general exocrine dysfunction. Arthritis Rheum (1987) 1.11
Overview of electrocardiographic and cardiovascular safety data for sparfloxacin. Sparfloxacin Safety Group. J Antimicrob Chemother (1996) 1.08
A targeted association study in systemic lupus erythematosus identifies multiple susceptibility alleles. Genes Immun (2010) 1.03
Methionine biosynthesis from the 4-carbon skeleton of ethionine in Saccharomyces cerevisiae. Biochem Biophys Res Commun (1968) 1.02
Purification of antigenically intact Ro ribonucleoproteins; biochemical and immunological evidence that the 52-kD protein is not a Ro protein. Clin Exp Immunol (1995) 1.01
Norfloxacin for prevention of bacterial infections in granulocytopenic patients. Am J Med (1987) 1.01
In vitro studies on peripheral blood leucocytes in rheumatoid arthritis. Ann Rheum Dis (1974) 1.01
Gene cloning, DNA sequencing, and expression of thermostable beta-mannanase from Bacillus stearothermophilus. Appl Environ Microbiol (1998) 1.00
Interaction cloning and characterization of RoBPI, a novel protein binding to human Ro ribonucleoproteins. RNA (2000) 0.99
Comparative esophageal and anorectal motility in scleroderma. Gastroenterology (1985) 0.92
Airway disease in a subset of nonsmoking rheumatoid patients. Characterization of the disease and evidence for an autoimmune pathogenesis. Am J Med (1982) 0.92
Heterogeneity of human Ro ribonucleoproteins (RNPS): nuclear retention of Ro RNPS containing the human hY5 RNA in human and mouse cells. Clin Exp Immunol (2001) 0.91
Anti-Ro (SSA) antibodies: clinical significance and biological relevance. J Rheumatol (1996) 0.91
Rheumatoid arthritis associated autoimmune systems. J Rheumatol (1998) 0.89
Eosinophilic synovitis: clinical observations on a newly recognized subset of patients with dermatographism. Arthritis Rheum (1986) 0.89
Role of homocysteine synthetase in an alternate route for methionine biosynthesis in Saccharomyces cerevisiae. J Bacteriol (1970) 0.89
Clinical significance of anti-Ro(SSA) antibody in rheumatoid arthritis. J Rheumatol (1988) 0.88
Rheumatoid arthritis: anti-Ro antibodies define a non-HLA-DR4 associated clinicoserological cluster. J Rheumatol (1993) 0.88
The Relationship Between Function and Disease Activity as Measured by the HAQ and DAS28 Varies Over Time and by Rheumatoid Factor Status in Early Inflammatory Arthritis (EIA). Results from the CATCH Cohort. Open Rheumatol J (2013) 0.87
Autoantibodies in human anti-Ro sera specifically recognize deproteinized hY5 Ro RNA. Clin Exp Immunol (1995) 0.85
Autoantigenic epitopes on hY5 Ro RNA are distinct from regions bound by the 60-kDa Ro and La proteins. J Immunol (1996) 0.84
IgG autoantibody response in HTLV-I-infected patients. Clin Immunol Immunopathol (1995) 0.83
Assessment of salsalate, a nonacetylated salicylate, in the treatment of patients with arthritis. Clin Ther (1996) 0.82
Use of a hapten-carrier system in experimental immune arthritis in the rabbit. Arthritis Rheum (1977) 0.82
In vitro irradiation of basement membrane enhances the invasiveness of breast cancer cells. Br J Cancer (2007) 0.82
Is local antigen persistence responsible for the chronicity of the experimental immune arthritis of the rabbit. Experientia (1976) 0.82
[Detection of antinuclear factors in rheumatic diseases]. Union Med Can (1974) 0.82
Purification and properties of a novel enzyme, L-alpha-amino-epsilon-caprolactamase from Cryptococcus laurentii. FEBS Lett (1978) 0.81
Identification of ribonucleoprotein (RNP)-specific protein interactions using a yeast RNP interaction trap assay (RITA). Biotechniques (1999) 0.80
Expression of recombinant human cyclooxygenase isoenzymes in transfected COS-7 cells in vitro and inhibition by tenoxicam, indomethacin and aspirin. Prostaglandins Leukot Essent Fatty Acids (1997) 0.80
De novo synthesis of proteinase 3 by cytokine primed circulating human polymorphonuclear neutrophils and mononuclear cells. J Rheumatol (2000) 0.80
[Antineutrophil cytoplasmic antibodies in human pathologies]. Union Med Can (1993) 0.80
Expression of prostaglandin endoperoxide synthase-1 and prostaglandin endoperoxide synthase-2 in human osteoblasts. Biochem Biophys Res Commun (1994) 0.80
[Diagnosis of gout: problems caused by crystallization "in vitro" of sodium urate]. Union Med Can (1979) 0.78
Evaluation of in vitro activity of quinupristin/dalfopristin and comparator antimicrobial agents against worldwide clinical trial and other laboratory isolates. Am J Med (1998) 0.78
Finding a valid model for antineutrophil cytoplasmic antibody-related vasculitis. Arthritis Rheum (1997) 0.77
Effects of probiotics strain MA18/5M and subsp. strain SB-CNCM I-1079 on fecal and intestinal microbiota of nursing and weanling piglets. J Anim Sci (2015) 0.77
snRNPs and scRNPs as autoantigens: clues to the etiology of the connective tissue diseases. Clin Rheumatol (1990) 0.76
Detection of anti-neutrophil cytoplasmic antibodies by immunoprecipitation. Clin Invest Med (1995) 0.76
Chronic modulation of the autoimmune response following parvovirus B19 infection. J Rheumatol (1994) 0.76
RNA-labelled Ro and La ribonucleoprotein complexes reassembled in vitro; characterization by gel shift analysis. Clin Exp Immunol (1996) 0.76
Cross-reactivity of an anti-proteinase 3 antibody to elastase. Autoimmunity (1994) 0.75
Skin temperature of the knee: an unrecognized physical sign of inflammatory disease of the knee. Can Med Assoc J (1980) 0.75
On the origin of surface proteinase 3 of nonmyeloid cells: evidence favoring an exogenous source. Clin Immunol (2000) 0.75
Clinical and serological identification of 2 forms of complete heart block in children. J Rheumatol (1995) 0.75
Efficacy and tolerability of enteric-coated naproxen in the treatment of osteoarthritis and rheumatoid arthritis: a double-blind comparison with standard naproxen followed by an open-label trial. Curr Med Res Opin (1992) 0.75
Cross-reactivity of an anti-proteinase 3 antibody to elastase. Autoimmunity (1993) 0.75
[Clinical ethics and observations on death]. Union Med Can (1993) 0.75
[Polymyositis induced by D-penicillamine treatment of rheumatoid arthritis: apropos of 2 cases with antinuclear antibodies]. Union Med Can (1986) 0.75
Malignancy prevalence in the first-degree relatives of persons with systemic lupus erythematous: a pilot study. Lupus (2006) 0.75
Southern blotting of long-term preserved DNA. Biotechniques (1997) 0.75
[Immunofluorescent deposits in normal rheumatoid skin]. Ann Immunol (Paris) (1977) 0.75
[Antinuclear antibodies and PHA response in rheumatoid arthritis]. Ann Immunol (Paris) (1977) 0.75
N-Acetyl-beta-hexosaminidase isoenzymes of amniotic fluid and maternal serum. Their relevance to prenatal diagnosis of the GM2 gangliosidoses. Clin Chim Acta (1977) 0.75
Elemental contamination in Vacutainer tubes used for blood collection. Int J Nucl Med Biol (1983) 0.75
[Rheumatoid polyarthritis: increase of M cells in blood mononuclear subpopulations]. Union Med Can (1976) 0.75
[From the molecule to the drug: innovation or distribution]. Union Med Can (1993) 0.75
Trace element contamination in blood-collecting devices. Int J Nucl Med Biol (1979) 0.75
Ciprofloxacin treatment of periapical Pseudomonas aeruginosa infection. Endod Dent Traumatol (1988) 0.75
[Serum zinc, copper and sulfhydryl groups in osteoarthritis and rheumatoid arthritis]. Union Med Can (1980) 0.75
Open-label tolerability study of enteric-coated naproxen in the treatment of osteoarthritis and rheumatoid arthritis. Curr Med Res Opin (1992) 0.75
Immunological cross-reactivity of adenovirus structural proteins. J Virol Methods (1986) 0.75
[Textually transmitted diseases]. Union Med Can (1992) 0.75
Patient compliance with tenoxicam in family practice. Clin Ther (1994) 0.75
Heterogeneity of ANCA sera showing atypical, peripheral and classical cytoplasmic immunofluorescence patterns. Adv Exp Med Biol (1993) 0.75
Stiffness of the rib cage in a subset of rheumatoid patients. Lung (1988) 0.75
Charcot-Leyden crystals in synovial fluid. Arthritis Rheum (1981) 0.75
Operationally defined single- and double-stranded DNA antigens in the Farr assay: diagnostic value. Eur J Clin Invest (1979) 0.75
[Genetics of the 3d type]. Union Med Can (1993) 0.75
[New strategies of the Medical Research Council of Canada]. Union Med Can (1993) 0.75